The Pfizer drug, known as a protease inhibitor, is designed to block an enzyme the virus needs in order to multiply. EKO HOT BLOG reports that an experimental pill to treat COVID-19 developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest. The … Read more
…Only China, Cuba and the United Arab Emirates have so far approved COVID-19 jabs for younger children. EKO HOT BLOG reports that the United States’s COVID-19 vaccination programme for children between the ages of 5 and 11 will be “running at full strength” as of next week, the White House has announced, a significant milestone … Read more
Several countries have already approved COVID-19 booster shots to increase immunity in people who have already been vaccinated… EKO HOT BLOG reports that a booster shot of the anti COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 per cent effective against symptomatic infection. This is according to trial data published by Pfizer’s manufacturers on Thursday. The … Read more
Vaccine effectiveness against the Delta variant was 93% after the first month, declining to 53% after four months… The effectiveness of the Pfizer COVID-19 vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose. This is according to a data published on Monday that US health agencies … Read more
…COVID-19 vaccines are only approved for children 12 and older, which has stirred concern among health experts as cases in children increase… Pfizer/BioNTech plans to ask for authorization of a COVID-19 vaccine for children under 12 soon. This brings the US one step closer to offering protection to a population that has grown particularly vulnerable … Read more
Sixteen African countries are now seeing a resurgence of the virus, with the more contagious Delta strain detected in 10 of them Africa has just lived through its most devastating week of the COVID-19 pandemic, but the worst is yet to come as the third wave gathers pace on the continent, the World Health Organization … Read more
The FDA previously granted an emergency use authorization for the Pfizer-BioNTech vaccine to individuals aged 16 and older The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years old. “This is a promising development in our fight against the virus,” said … Read more